Solid Dosage
With our comprehensive portfolio of oral solid dosage solutions, we can supply full process lines with containment interfaces for process steps from API and excipient dispensing, dry milling, powder collection and blending through to tableting and coating.
With an increasing emphasis on both operator safety and product protection, the commercial-scale production of oncology drugs, hormonal products and/or other highly potent compounds has been put under the pharmaceutical spotlight in recent years.
Eliminating the need for cumbersome isolation suits to prevent operators being exposed to hazardous substance and avoid cross-contamination with other products manufactured in the same facility, GEA’s approach is to use containment interfaces (the BUCK® MC high-containment range and disposable Hicoflex® products) to ensure compliance with global regulatory cGMP requirements.
Experts in contained material handling, closed product processing, gentle product treatment, the efficient recovery of active ingredients and reliable scale-up, we supply modules, components and fully integrated batch and continuous lines for the production of oncology drugs and other therapeutic agents that deliver increased yields and reduced cycle times.
From R&D-scale and standalone production equipment to contained production lines, we understand the absolute importance of preventing cross-contamination in the production area, protecting both people and products, and working within Real Daily Intake (RDI) and Acceptable Daily Intake (ADI) limits with up to occupational exposure band (OEB) 5 drugs.
GEA has a wealth of expertise and an unparalleled depth of experience in the field of containment. The company not only offers a comprehensive range of robust and compliant containment products, it also boasts unrivaled experience in identifying the most appropriate solution and a thorough understanding of containment risk analysis.
Affichage de 4 sur 25
En tant qu’intégrateurs de systèmes, nous associons notre savoir faire en matière de technologie de process et d'engineering aux logiciels de contrôle commande et de supervision développés par des leaders du marché.
Contained Materials Handling solutions for Primary and Secondary Pharmaceuticals and Healthcare. With extensive experience within the generics sector, supply a wide range of technologies and equipment that improve and enhance the efficiency and performance of Oral Solid Dosage production.
The ConsiGma® DC for direct compression is the latest expansion of GEA's continuous portfolio for cost effective, compact, high yield manufacturing systems. It offers a robust and flexible manufacturing method for a wide range of products.
Continuous Processing is becoming more and more important in the pharmaceutical industry. GEA takes the lead in introducing this innovative technology with ConsiGma® - continuous high-shear granulation and drying lines.
Pour nous, chez GEA, la réduction des déchets est importante. Nous sommes conscients qu’en exploitant la puissance de la technologie de la lyophilisation, nous pouvons transformer les denrées alimentaires en excédent en produits de valeur qui dureront longtemps, pour aider à réduire les déchets, allonger la durée de conservation et mettre en place un système agroalimentaire plus résilient pour les générations à venir.
Lorsque le producteur de denrées alimentaires à base végétale sud-coréen Pulmuone a mis GEA au défi de moderniser ses nouilles froides traditionnelles, les « naengmyeon », les spécialistes R&D de GEA ont saisi la balle au bond. Ils ont aidé l’entreprise à développer un plat, qui est aujourd’hui une vraie réussite commerciale et dont la production consomme moins d’eau et d’électricité que les méthodes qui existaient auparavant. Le résultat est, par ailleurs, fidèle aux origines traditionnelles de ce plat et aux racines de Pulmuone, qui sont la santé, le bien-être et le développement durable.